No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GH Guardant Health
- 25.520
- +3.010+13.37%
Close May 24 16:00 ET
- 25.490
- -0.030-0.12%
Post 19:40 ET
3.12BMarket Cap-6510P/E (TTM)
26.361High23.345Low6.01MVolume26.220Open22.510Pre Close150.54MTurnover5.48%Turnover RatioLossP/E (Static)122.37MShares41.06052wk High45.73P/B2.80BFloat Cap15.81052wk Low--Dividend TTM109.82MShs Float181.070Historical High--Div YieldTTM13.40%Amplitude15.810Historical Low25.034Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Guardant Health Shares Rise 10% on Recommendation to Approve Blood Test for Cancer Screening
Guardant Health shares rose 10% in premarket trading after a regulatory advisory panel recommended for approval the company's blood test for cancer screening.
Evaluating Guardant Health: Insights From 5 Financial Analysts
In the preceding three months, 5 analysts have released ratings for Guardant Health (NASDAQ:GH), presenting a wide array of perspectives from bullish to bearish.In the table below, you'll find a summa
Research Alert: CFRA Maintains Buy Opinion On Shares Of Guardant Health, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $3
Express News | Stephens & Co. Reiterates Overweight on Guardant Health, Maintains $44 Price Target
Guardant Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/24/2024 84.99% Stephens & Co. → $44 Reiterates Overweight → Overweight 04/29/2024 26.13% Canaccord Genu
Deckers Outdoor +13% Posts Upbeat Earnings, Joins PDD, Magnite, Merus Climbing
U.S. stocks were higher, with the Nasdaq Composite gaining around 80 points on Friday.Shares of Deckers Outdoor Corporation (NYSE:DECK) rose sharply during Friday's session after the company reported
Comments
Guardant Health is undervalued, making it a good time to accumulate more holdings. The company's positive future outlook isn't fully reflected in the current share price. Consider financial health before investing.
Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)? 1
The recent share price drop may indicate unresolved challenges, despite the company's revenue growth. Investors are advised to ensure they are buying a high-quality business, even when the share price is low.
Guardant Health's high P/S ratio is due to strong revenue performance and promising future growth rates, bolstering shareholder confidence. Given the optimism, a significant stock price drop is unlikely soon.
Substantial insider acquisitions point to optimism for the company's prospects. However, the recent sale by the CIO may suggest some insiders think shares are overvalued. Still, high insider ownership implies alignment of management's interests with shareholders.
Wolfe Research Downgrades $Snowflake(SNOW.US$ to Peer Perform From Outperform
Snowflake (SNOW) has an average rating of outperform and price targets ranging from $105 to $500, according to analysts polled by Capital IQ.
Guggenheim Downgrades $MongoDB(MDB.US$ to Sell From Neutral, Adjusts Price Target to $210 From $205
MongoDB (MDB) has an average rating of outperform and price targets ranging from $180 to $365, according to analysts po...
Snowflake (SNOW) has an average rating of outperform and price targets ranging from $105 to $500, according to analysts polled by Capital IQ.
Guggenheim Downgrades $MongoDB(MDB.US$ to Sell From Neutral, Adjusts Price Target to $210 From $205
MongoDB (MDB) has an average rating of outperform and price targets ranging from $180 to $365, according to analysts po...
18
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg